Silva Pharmaceuticals Limited (DSE:SILVAPHL)
Bangladesh
· Delayed Price · Currency is BDT 9.10
+0.20 (2.25%)
At close: Mar 9, 2026
Silva Pharmaceuticals Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 37.38 | 38.77 | 38.69 | 28.64 | 36.43 | 58.66 | Upgrade
|
| Short-Term Investments | 74.21 | 64.03 | 88.8 | 152.72 | 225.04 | 211.67 | Upgrade
|
| Cash & Short-Term Investments | 111.59 | 102.8 | 127.49 | 181.37 | 261.47 | 270.33 | Upgrade
|
| Cash Growth | -18.51% | -19.37% | -29.70% | -30.64% | -3.28% | 12.90% | Upgrade
|
| Accounts Receivable | 208.99 | 229.47 | 255.72 | 257.35 | 255.05 | 269.91 | Upgrade
|
| Other Receivables | 0.33 | 0.14 | 0.41 | 1.97 | 2.56 | 2.3 | Upgrade
|
| Receivables | 209.32 | 229.62 | 256.13 | 259.32 | 257.61 | 272.21 | Upgrade
|
| Inventory | 406.44 | 443.01 | 493.2 | 493.72 | 482.29 | 464.18 | Upgrade
|
| Other Current Assets | 63.11 | 54.4 | 62.69 | 66.02 | 61.79 | 68.21 | Upgrade
|
| Total Current Assets | 790.47 | 829.84 | 939.52 | 1,000 | 1,063 | 1,075 | Upgrade
|
| Property, Plant & Equipment | 1,395 | 1,420 | 1,473 | 1,501 | 1,480 | 1,371 | Upgrade
|
| Other Intangible Assets | 2.3 | 2.42 | 1.22 | 1.36 | 1.51 | 1.68 | Upgrade
|
| Total Assets | 2,187 | 2,252 | 2,414 | 2,503 | 2,545 | 2,447 | Upgrade
|
| Accounts Payable | 14.19 | 9.97 | 7.16 | 6.99 | 6.9 | 6.25 | Upgrade
|
| Accrued Expenses | 9.59 | 9.76 | 11.85 | 12.43 | 16.25 | 15.28 | Upgrade
|
| Short-Term Debt | 29.26 | 28.22 | 47.71 | 55.84 | 91.01 | 29.14 | Upgrade
|
| Current Portion of Leases | 1.04 | 1.07 | 1.18 | 1.42 | 2.34 | 5.67 | Upgrade
|
| Current Income Taxes Payable | 8.77 | 6.47 | 5.45 | 7.9 | 19.03 | 30.63 | Upgrade
|
| Other Current Liabilities | 0.14 | 0.21 | 0.82 | 1.62 | 2.59 | 1.52 | Upgrade
|
| Total Current Liabilities | 62.99 | 55.7 | 74.16 | 86.19 | 138.11 | 88.48 | Upgrade
|
| Long-Term Leases | 1.73 | 2.31 | 3.44 | 4.6 | 5.75 | 7.9 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 81.1 | 81.27 | 80.68 | 77.86 | 75.68 | 80.3 | Upgrade
|
| Total Liabilities | 145.82 | 139.28 | 158.28 | 168.65 | 219.54 | 176.68 | Upgrade
|
| Common Stock | 1,365 | 1,365 | 1,365 | 1,365 | 1,365 | 1,365 | Upgrade
|
| Retained Earnings | 676.55 | 748.04 | 890.95 | 969.08 | 960.2 | 905.47 | Upgrade
|
| Shareholders' Equity | 2,042 | 2,113 | 2,256 | 2,334 | 2,325 | 2,270 | Upgrade
|
| Total Liabilities & Equity | 2,187 | 2,252 | 2,414 | 2,503 | 2,545 | 2,447 | Upgrade
|
| Total Debt | 32.03 | 31.6 | 52.33 | 61.86 | 99.09 | 42.71 | Upgrade
|
| Net Cash (Debt) | 79.57 | 71.21 | 75.17 | 119.51 | 162.38 | 227.62 | Upgrade
|
| Net Cash Growth | -6.82% | -5.27% | -37.10% | -26.40% | -28.67% | 17.48% | Upgrade
|
| Net Cash Per Share | 0.58 | 0.52 | 0.55 | 0.88 | 1.19 | 1.67 | Upgrade
|
| Filing Date Shares Outstanding | 136.5 | 136.5 | 136.5 | 136.5 | 136.5 | 136.5 | Upgrade
|
| Total Common Shares Outstanding | 136.5 | 136.5 | 136.5 | 136.5 | 136.5 | 136.5 | Upgrade
|
| Working Capital | 727.48 | 774.14 | 865.35 | 914.23 | 925.05 | 986.45 | Upgrade
|
| Book Value Per Share | 14.96 | 15.48 | 16.53 | 17.10 | 17.03 | 16.63 | Upgrade
|
| Tangible Book Value | 2,039 | 2,111 | 2,255 | 2,333 | 2,324 | 2,269 | Upgrade
|
| Tangible Book Value Per Share | 14.94 | 15.46 | 16.52 | 17.09 | 17.02 | 16.62 | Upgrade
|
| Land | 342.77 | 342.77 | 342.77 | 342.77 | 342.77 | 342.77 | Upgrade
|
| Buildings | 424.09 | 424.09 | 424.09 | 424.09 | 424.09 | 424.09 | Upgrade
|
| Machinery | 1,149 | 1,149 | 1,149 | 1,090 | 1,072 | 998.72 | Upgrade
|
| Construction In Progress | 324.46 | 323.28 | 317.67 | 343.47 | 274.25 | 178.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.